Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives

References

• Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med. 1972;52(2):149–159. doi:10.1016/0002-9343(72)90064-2
   Web of Science ®Google Scholar
• Sharp GC. Diagnostic criteria for classification of MCTD. In: Kasukawa R, Sharp GC, editors. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division); 1987:23–30.
   Google Scholar
• Alarcón-Segovia D, Villarreal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed Connective Tissue Disease and Antinuclear Antibodies. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division); 1987:33–40.
   Google Scholar
• Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed Connective Tissue Disease and Anti-Nuclear Antibodies. Amsterdam: Elsevier Science Publishers B.V. (Biomedical Division); 1987:41–47.
   Google Scholar
• Kahn MF, Appelboom T. Syndrome de Sharp. In: Kahn MF, Peltier AP, Mayer O, Piette JC, editors. Les maladies systémiques. 3rd ed. Paris: Flammarion; 1991:545–556.
   Google Scholar
• Tanaka Y, Kuwana M, Fujii T, et al. 2019 Diagnostic criteria for mixed connective tissue disease (MCTD): from the Japan Research Committee of the Ministry of Health, Labor, and Welfare for systemic autoimmune disease. Mod Rheumatol. 2021;31(1):29–33. doi:10.1080/14397595.2019.1709944
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Crowson CS, Chowdhary VR, Ernste FC, Moder KG, Matteson EL. Epidemiology of mixed connective tissue disease, 1985–2014: a population-based study. Arthritis Care Rex. 2016;68(12):1843–1848. doi:10.1002/acr.22872
   PubMed Web of Science ®Google Scholar
• Gunnarson R, Molberg O, Gilboe IM, Gran JT. The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients. Ann Rheum Dis. 2011;70(6):1047–1051. doi:10.1136/ard.2010.143792
   PubMed Web of Science ®Google Scholar
• Hoffman RW, Rettenmaier LJ, Takeda Y, et al. Human autoantibodies against the 70-kD polypeptide of U1 small nuclear RNP are associated with HLA-Dr4 among connective tissue disease patients. Arthr Rheum. 1990;33:666–673. doi:10.1002/art.1780330509
   PubMedGoogle Scholar
• Zhao N, Smargiassi A, Chen H, Widdifield J, Bernatsky S. Systemic autoimmune rheumatic diseases and multiple industrial air pollutant emissions: a large general population Canadian cohort analysis. Environ Int. 2023;174:107920. doi:10.1016/j.envint.2023.107920
   PubMed Web of Science ®Google Scholar
• Prokop J, Jagodzinski PP. Identification of retroviral conserved pol sequences in serum of mixed connective tissue disease and systemic sclerosis patients. Biomed Pharmacother. 2004;58(1):61–64. doi:10.1016/j.biopha.2003.10.001
   PubMed Web of Science ®Google Scholar
• Lerner MR, Steitz JA. Antibodies to small nuclear RNAs complexed with proteins are produced by patients with systemic lupus erythematosus. Proc Natl Acad Sci. 1979;76(11):5495–5499. doi:10.1073/pnas.76.11.5495
   PubMed Web of Science ®Google Scholar
• Greidinger EL, Zang YJ, Jaimes K, Martinez L, Nassiri M, Hoffman RW. CD4+ T cells target epitopes residing within the RNA-binding domain of the U1-70-kDa small nuclear ribonucleoprotein autoantigen and have restricted TCR diversity in an HLA-Dr4-transgenic murine model of mixed connective tissue disease. J Immunol. 2008;180(12):8444–8454. doi:10.4049/jimmunol.180.12.8444
   PubMed Web of Science ®Google Scholar
• Keith MP, Moratz C, Tsokos GC. Anti-RNP immunity: implication for tissue injury and the pathogenesis of connective tissue disease. Autoimmun Rev. 2007;6(4):232–236. doi:10.1016/j.autrev.2006.08.007
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A. U1-RNP and TLR receptors in the pathogenesis of mixed connective tissue disease. Part I. The U1-RNP complex and its biological significance in the pathogenesis of mixed connective tissue disease. Reumatologia. 2015;53(3):94–100. doi:10.5114/reum.2015.51509
   PubMedGoogle Scholar
• Hof D, Cheung K, De Rooij D, et al. Autoantibodies specific for apoptotic U1-70K are superior serological markers for mixed connective tissue disease. Arthritis Res Ther. 2005;7(2):R302–9. doi:10.1186/ar1490
   PubMed Web of Science ®Google Scholar
• Xiang W, Dong R, Li M, Liu B, Ma Z, Yang Q. The role of anti-U1 RNP antibody in connective tissue disease-associated pulmonary artery hypertension: a systematic review and meta-analysis. J Clin Med. 2023;12(1):13. doi:10.3390/jcm12010013
   Web of Science ®Google Scholar
• Sen S, Sinhamahapatra P, Chudhuri S, et al. Cutaneous manifestations of mixed connective tissue disease: study from a tertiary care hospital in eastern India. Indian J Dermatol. 2014;59(1):35–40. doi:10.4103/0019-5154.123491
   PubMed Web of Science ®Google Scholar
• Pope JE. Other manifestations of mixed connective tissue disease. Rheum Dis Clin North Am. 2005;31(3):519–533. doi:10.1016/j.rdc.2005.04.011
   PubMed Web of Science ®Google Scholar
• Takasaki Y, Yamanaka K, Takasaki C, et al. Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease. Mod Rheumatol. 2004;14(5):367. doi:10.3109/s10165-004-0325-2
   PubMedGoogle Scholar
• Ramos-Niembro F, Alarcon-Segovia D, Hernandez-Ortiz J. Articular manifestation of mixed connective tissue disease. Arthritis Rheum. 1979;22(1):43. doi:10.1002/art.1780220107
   PubMedGoogle Scholar
• Hall S, Hanrahan P. Muscle involvement in mixed connective tissue disease. Rheum Dis Clin North Am. 2005;31(2):509. doi:10.1016/j.rdc.2005.04.003
   PubMedGoogle Scholar
• Vianna MA, Borges CT, Borba EF, Caleiro MT, Bonfà E, Marie SK. Myositis in mixed connective tissue disease: a unique syndrome characterized by immunohistopathologic elements of both polymyositis and dermatomyositis. Arq neuropsiquiatr. 2004;62(4):923. doi:10.1590/S0004-282X2004000600001
   PubMed Web of Science ®Google Scholar
• Sambataro G, Ferrara CA, Spadaro C, et al. A new method for the assessment of myalgia in interstitial lung disease: association with positivity for myositis-specific and myositis-associated antibodies. Diagnostics. 2022;12(5):1139. doi:10.3390/diagnostics12051139
   Web of Science ®Google Scholar
• Nica AE, Alexa LM, Ionescu AO, Andronic O, Padararu DN. Esophageal disorders in mixed connective tissue disease. J Med Life. 2016;9(2):141–143.
   PubMedGoogle Scholar
• Marshall JB, Kretschmar JM, Gerhardt DC, et al. gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology. 1990;98(5 pt 1):1232. doi:10.1016/S0016-5085(12)90338-8
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Wannatong T, Panichsillapakit T, et al. Cardiac involvement in mixed connective tissue disease: a systematic review. Int J Cardiol. 2014;171(3):326–330. doi:10.1016/j.ijcard.2013.12.079
   PubMed Web of Science ®Google Scholar
• Alpert MA, Goldberg SH, Singsen BH, et al. cardiovascular manifestations of mixed connective tissue disease in adults. Circulation. 1983;68(6):1182. doi:10.1161/01.CIR.68.6.1182
   PubMed Web of Science ®Google Scholar
• Chaigne B, Chevalier K, Boucly A, et al. In-depth characterization of pulmonary arterial hypertension in mixed connective tissue disease: a French national multicenter study. Rheumatology. 2023. doi:10.1093/rheumatology/kead055
   Web of Science ®Google Scholar
• Fayed H, Coghlan JG. Pulmonary hypertension associated with connective tissue disease. Semin Respir Crit Care med. 2019;40(2):173–183. doi:10.1055/s-0039-1685214
   PubMed Web of Science ®Google Scholar
• Jeganathan N, Sathananthan M. Connective tissue disease-related interstitial lung disease: prevalence, patterns, predictors, prognosis, and treatment. Lung. 2020;198(5):735. doi:10.1007/s00408-020-00383-w
   PubMed Web of Science ®Google Scholar
• Sambataro D, Sambataro G, Pignataro F, et al. Patients with interstitial lung disease secondary to autoimmune diseases: how to recognize them? Diagnostics. 2020;10(4):208. doi:10.3390/diagnostics10040208
   Web of Science ®Google Scholar
• Prakash UBS. Respiratory complications in mixed connective tissue disease. Clin Chest Med. 1998;19(4):733–746. doi:10.1016/S0272-5231(05)70113-1
   PubMed Web of Science ®Google Scholar
• Bennett RM, Bong DM, Spargo BH. Neuropsychiatric problems in mixed connective tissue disease. Am J Med. 1978;65(6):955. doi:10.1016/0002-9343(78)90747-7
   PubMed Web of Science ®Google Scholar
• Hojaili B, Barland P. Trigeminal neuralgia as the first manifestation of mixed connective tissue disorder. J Clin Rheumatol. 2006;12(3):145. doi:10.1097/01.rhu.0000222045.70861.a5
   PubMed Web of Science ®Google Scholar
• Lundberg IE. The prognosis of mixed connective tissue disease. Rheum Dis Clin North Am. 2005;31(3):535. doi:10.1016/j.rdc.2005.04.005
   PubMed Web of Science ®Google Scholar
• Kitridou RC, Akmal M, Turkel SB, Ehresmann GR, Quismorio FB, Massry SG. Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study. Semin Arthritis Rheum. 1986;16(2):135. doi:10.1016/0049-0172(86)90047-8
   PubMed Web of Science ®Google Scholar
• John KJ, Sadiq M, George T, et al. Clinical and immunological profile of mixed connective tissue disease and a comparison of four diagnostic criteria. Int J Rheumatol. 2020;2020:9692030. doi:10.1155/2020/9692030
   PubMed Web of Science ®Google Scholar
• Wanzenried A, Garaiman A, Jordan S, Distler O, Maurer B. the enigma of mixed connective tissue disease- challenges in routine care. Clin Rheumatol. 2022;41(11):3503–3511. doi:10.1007/s10067-022-06286-w
   PubMed Web of Science ®Google Scholar
• Cappelli S, Bellando Randone S, Martinović D, et al. ”To be or not to be”, ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41(4):589–598. doi:10.1016/j.semarthrit.2011.07.010
   PubMed Web of Science ®Google Scholar
• Ciancio N, Pavone M, Torrisi SE, et al. Contribution of pulmonary function tests (PFTs) to the diagnosis and follow up of connective tissue diseases. Multidiscip Respir Med. 2019;15:14–17.
   Google Scholar
• Maddison PJ, Reichlin M. Quantitation of precipitating antibodies to certain soluble nuclear antigens in SLE. Arthritis Rheum. 1977;20(3):819–824. doi:10.1002/art.1780200310
   PubMedGoogle Scholar
• Chan EKL, von Muhlen CA, Fritzler MJ, et al. The international Consensus on ANA patterns (ICAP) in 2021- the 6th workshop and current perspectives. J Appl Lab Med. 2022;7(1):322–330. doi:10.1093/jalm/jfab140
   PubMedGoogle Scholar
• Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Eng J Med. 2003;349(16):1526–1533. doi:10.1056/NEJMoa021933
   PubMed Web of Science ®Google Scholar
• Usuba FS, Lopez JB, Guller R, et al. Sjӧgren’s syndrome: an underdiagnosed condition in mixed connective tissue disease. Clinics. 2014;69(3):158–162. doi:10.6061/clinics/2014(03)02
   PubMed Web of Science ®Google Scholar
• Pizzorni C, Ferrari G, Schenone C, et al. Capillaroscopic analysis of the microvascular status in mixed versus undifferentiated connective tissue disease. Microvasc Res. 2022;142:104367. doi:10.1016/j.mvr.2022.104367
   PubMed Web of Science ®Google Scholar
• De Holanda Mafaldo Diofenes A, Bonfà E, Fuller R, Correia Caleiro MT. Capillaroscopy is a dynamic process in mixed connective tissue disease. Lupus. 2007;16(4):254–258. doi:10.1177/0961203307076517
   PubMed Web of Science ®Google Scholar
• Todoroki Y, Kubo S, Nakano K, et al. Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD. Rheumatology. 2022;61(12):4875–4884. doi:10.1093/rheumatology/keac165
   PubMed Web of Science ®Google Scholar
• Sambataro D, Sambataro G, Libra A, et al. Nailfold videocapillaroscopy is a useful tool to recognize definite forms of systemic sclerosis and idiopathic inflammatory myositis in interstitial lung disease patients. Diagnostics. 2020;10(5):253. doi:10.3390/diagnostics10050253
   Web of Science ®Google Scholar
• Manfredi A, Sebastiani M, Cassone G, et al. Nailfold Capillaroscopic changes in dermatomyositis and polymyositis. Clin Rheumatol. 2015;34(2):279–284. doi:10.1007/s10067-014-2795-8
   PubMed Web of Science ®Google Scholar
• Kawano-Dourado L, Baldi BG, Kay FU, et al. Pulmonary involvement in long-term mixed connective tissue disease: functional trends and image findings after 10 years. Clin Exp Rheumatol. 2015;33(2):234–240.
   PubMed Web of Science ®Google Scholar
• Wijsenbeek M, Cottin V. Spectrum of fibrotic lung disease. N Eng J Med. 2020;383(10):958. doi:10.1056/NEJMra2005230
   PubMed Web of Science ®Google Scholar
• Flaherty KR, Wells AU, Cottin V, et al. Nintedanib in progressive fibrosing interstitial lung diseases. N Eng J Med. 2019;381(19):1718. doi:10.1056/NEJMoa1908681
   PubMedGoogle Scholar
• Sambataro G, Vancheri A, Torrisi SE, et al. The morphological domain does not affect the rate of progression to defined autoimmune diseases in patients with interstitial pneumonia with autoimmune features. Chest. 2020;157(1):238–242. doi:10.1016/j.chest.2019.08.2175
   PubMed Web of Science ®Google Scholar
• Sambataro G, Ferrara CA, Torrisi SE, et al. “Usual” Interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients. Clin Exp Rheumatol. 2022;40(7):1324–1329. doi:10.55563/clinexprheumatol/lqi6z7
   PubMed Web of Science ®Google Scholar
• Sambataro G, Sambataro D, Spicuzza L, et al. Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study. Clin Exp Rheumatol. 2022. doi:10.55563/clinexprheumatol/lycdca
   Web of Science ®Google Scholar
• Palmucci S, Galioto F, Fazio G, et al. Clinical and radiological features of lung disorders related to connective-tissue diseases: a pictorial assay. Insights Imaging. 2022;13:108. doi:10.1186/s13244-022-01243-2
   PubMed Web of Science ®Google Scholar
• Topyla-çPutowska W, Tomaszewski M, Wysokinski A, Tomaszewski A. Echocardiography in pulmonary arterial hypertension: comprehensive evaluation and technical considerations. J Clin Med. 2021;10(15):3229. doi:10.3390/jcm10153229
   PubMed Web of Science ®Google Scholar
• Bournia VK, Tsangaris I, Rallidis L, et al. Cardiac catheterization versus echocardiography for monitoring pulmonary pressure: a prospective study in patients with connective tissue disease-associated pulmonary artery hypertension. Diagnostics. 2020;10(1):49. doi:10.3390/diagnostics10010049
   Web of Science ®Google Scholar